» Articles » PMID: 37781508

Tofacitinib Promotes Functional Recovery After Spinal Cord Injury by Regulating Microglial Polarization Via JAK/STAT Signaling Pathway

Overview
Journal Int J Biol Sci
Specialty Biology
Date 2023 Oct 2
PMID 37781508
Authors
Affiliations
Soon will be listed here.
Abstract

The JAK/STAT signaling pathway is the main inflammatory signal transduction pathway, whether JAK/STAT contributes the pathology of SCI and targeting the pathway will alleviate SCI needs to be addressed. Here, we explored the therapeutic effect of pan-JAK inhibitor tofacitinib (TOF) on secondary injury after SCI and explained the underlying mechanisms. SCI model in rat was established to evaluate the therapeutic effects of TOF treatment . Histological and behavioral analyses were performed at different time points after SCI. , the effects of TOF on pro-inflammatory activation of primary microglia and BV2 cells were analyzed by western blot analysis, fluorescent staining, qPCR and flow cytometry. The neuroprotection of TOF was detected using a co-culture system with primary neurons and microglia. TOF can effectively improve motor dysfunction caused by spinal cord injury in rats. TOF administration in the early stage of inflammation can effectively inhibit neuronal apoptosis and scar tissue formation, and promote the repair of axons and nerve fibers. Further studies have demonstrated that TOF suppresses inflammation caused by spinal cord injury by inhibiting the activation of microglia to pro-inflammatory phenotype and . Additionally, an interesting phenomenon is revealed in our results that TOF exhibits superior neuronal protection during inflammation . Our study showed that TOF could regulate microglial activation via JAK / STAT pathway and promote the recovery of motor function after SCI, which is of great significance for the immunotherapy of SCI.

Citing Articles

Synergistic restoration of spinal cord injury through hyaluronic acid conjugated hydrogel-polydopamine nanoparticles combined with human mesenchymal stem cell transplantation.

Kao Y, Song W, Zhang R, Gu G, Qiu H, Shen W Bioact Mater. 2025; 46:569-581.

PMID: 40027446 PMC: 11871414. DOI: 10.1016/j.bioactmat.2024.09.027.


Activation of the Nrf2 Signaling Pathway by Tetrahydroberberine Suppresses Ferroptosis and Enhances Functional Recovery Following Spinal Cord Injury.

Li X, Yu H, Liu R, Miao J, Lv J, Yang S Mol Neurobiol. 2025; .

PMID: 40011360 DOI: 10.1007/s12035-025-04791-y.


The role of natural products targeting macrophage polarization in sepsis-induced lung injury.

Li Y, Ai S, Li Y, Ye W, Li R, Xu X Chin Med. 2025; 20(1):19.

PMID: 39910395 PMC: 11800549. DOI: 10.1186/s13020-025-01067-4.


SIX1 aggravates the progression of spinal cord injury in mice by promoting M1 polarization of microglia.

Xu Z, Zhu M, Xie H, Zhu J, Zheng H, Liu X Sci Rep. 2025; 15(1):1283.

PMID: 39779741 PMC: 11711668. DOI: 10.1038/s41598-024-82121-3.


Tomatidine relieves neuronal damage in spinal cord injury by inhibiting the inflammatory responses and apoptosis through blocking the NF-κB/CXCL10 pathway activation.

Wang X, Huang W, Sun H, Wang H, Wang D, Wang Y Front Pharmacol. 2024; 15:1503925.

PMID: 39726790 PMC: 11669516. DOI: 10.3389/fphar.2024.1503925.


References
1.
Stalder R, Zhang B, Wrobel L, Boehncke W, Brembilla N . The Janus Kinase inhibitor tofacitinib impacts human dendritic cell differentiation and favours M1 macrophage development. Exp Dermatol. 2019; 29(1):71-78. DOI: 10.1111/exd.14059. View

2.
Wang C, Ma H, Zhang B, Hua T, Wang H, Wang L . Inhibition of IL1R1 or CASP4 attenuates spinal cord injury through ameliorating NLRP3 inflammasome-induced pyroptosis. Front Immunol. 2022; 13:963582. PMC: 9389052. DOI: 10.3389/fimmu.2022.963582. View

3.
Dowty M, Lin J, Ryder T, Wang W, Walker G, Vaz A . The pharmacokinetics, metabolism, and clearance mechanisms of tofacitinib, a janus kinase inhibitor, in humans. Drug Metab Dispos. 2014; 42(4):759-73. DOI: 10.1124/dmd.113.054940. View

4.
Lawrence T, Natoli G . Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol. 2011; 11(11):750-61. DOI: 10.1038/nri3088. View

5.
Latchney S, Masiulis I, Zaccaria K, Lagace D, Powell C, McCasland J . Developmental and adult GAP-43 deficiency in mice dynamically alters hippocampal neurogenesis and mossy fiber volume. Dev Neurosci. 2014; 36(1):44-63. PMC: 4035301. DOI: 10.1159/000357840. View